|
|
|
|
| LEADER |
04913nam a22003853i 4500 |
| 001 |
EBC6422751 |
| 003 |
MiAaPQ |
| 005 |
20231204023215.0 |
| 006 |
m o d | |
| 007 |
cr cnu|||||||| |
| 008 |
231204s2018 xx o ||||0 eng d |
| 020 |
|
|
|a 9783662564653
|q (electronic bk.)
|
| 020 |
|
|
|z 9783662564646
|
| 035 |
|
|
|a (MiAaPQ)EBC6422751
|
| 035 |
|
|
|a (Au-PeEL)EBL6422751
|
| 035 |
|
|
|a (OCoLC)1034550627
|
| 040 |
|
|
|a MiAaPQ
|b eng
|e rda
|e pn
|c MiAaPQ
|d MiAaPQ
|
| 050 |
|
4 |
|a R895-920
|
| 100 |
1 |
|
|a Speck, Ulrich.
|
| 245 |
1 |
0 |
|a X-Ray Contrast Media :
|b Overview, Use and Pharmaceutical Aspects.
|
| 250 |
|
|
|a 5th ed.
|
| 264 |
|
1 |
|a Berlin, Heidelberg :
|b Springer Berlin / Heidelberg,
|c 2018.
|
| 264 |
|
4 |
|c Ã2018.
|
| 300 |
|
|
|a 1 online resource (128 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a Intro -- CONTENT -- 1 INTRODUCTION -- Historical Aspects -- Contrast media in X-ray imaging -- Visualization of functions -- Morphology -- 2 GENERAL PRINCIPLES OF X-RAY CONTRAST MEDIA -- Physical Principles -- 3 STRUCTURE AND PROPERTIES OF X-RAY CONTRAST MEDIA -- Barium Sulfate -- Lipiodol -- Water-soluble contrast media -- Chemical structure, biological behavior and use -- High-osmolar, ionic contrast media -- Low-osmolar substances -- Nonionic contrast media -- Osmolality and side effects caused by hypertonicity -- Ionic contrast media -- Contrast media for intravenous cholegraphy -- Cations -- Synthesis of water-soluble contrast media -- 4 DEGRADATION OF IODINATED X-RAY CONTRAST MEDIA -- 5 PHYSICOCHEMICAL PROPERTIES OF WATER-SOLUBLE CONTRAST MEDIA -- Water solubility -- Viscosity/Temperature -- Osmolality -- Hydrophilia/Lipophilia -- Electrical charge -- Specific gravity/Density -- Others -- 6 PHARMACEUTICAL PRODUCT QUALITY -- Practical information at a glance -- Purity of the active ingredient, by-products and degradation products -- Formulations -- Additives -- Microbiological quality of the finished product -- Production under controlled environmental conditions -- Production process -- Sterile filtration, ultrafiltration and sterilization -- Sterility test -- Test for pyrogens -- Preservation of product quality in hospitals and practices -- Stability in long-term storage and at different temperatures -- Sensitivity to irradiation and light: white glass, brown glass, and UV-protective foil -- Tests for contamination with particles -- Risks of microbial contamination -- Transferring the contrast medium to sterile containers, disposable syringes, automatic injectors -- Transferring to sterile containers -- Drawing-up into disposable syringes or automatic injectors -- Use of large-volume CM bottles -- 7 PHARMACOLOGICAL PROPERTIES OF CM.
|
| 505 |
8 |
|
|a Biochemical-pharmacological properties -- Protein binding -- Complement activation -- Enzyme inhibition -- Influence on blood cells -- Histamine release -- Pharmacological-Toxicological Properties -- Tolerance limits -- Effects on the cardiovascular system -- Influence on renal function -- Allergic and pseudoallergic hypersensitivity reactions -- Endothelial damage -- Nervous system -- Pharmacokinetics -- 8 USES OF X-RAY CONTRAST MEDIA -- Modes of opacification -- 9 INTERACTIONS -- Influence on laboratory tests -- Interaction with medications -- Interaction of contrast media with additives and during interventional procedures -- Effects on blood coagulation -- 10 RISKS OF CONTRAST MEDIA USE -- Barium sulfate -- Ionic contrast media -- Nonionic contrast media -- Delayed reactions -- Causes of contrast media reactions -- General reactions (anaphylactoid reactions) -- Prophylaxis of general reactions -- Dose-dependent side effects -- Prophylaxis and therapy of severe iodine-induced hyperthyroidism -- Renal damage -- Renal insufficiency -- Plasmocytoma -- Diabetes mellitus -- Prophylaxis -- Pregnant patients -- Breast-feeding mothers -- Pheochromocytoma -- Sickle-cell anemia -- 11 DRUGS AND MEASURES FOR THE TREATMENT OF A CONTRAST MEDIUM REACTION -- Notes on the prophylaxis and therapy of X-ray contrast medium adverse effects -- Main risk factors* and prophylactic measures on use of X-ray contrast media -- First line treatment of contrast medium adverse reactions -- 12 FURTHER DEVELOPMENT OF CONTRAST MEDIA -- REFERENCES.
|
| 588 |
|
|
|a Description based on publisher supplied metadata and other sources.
|
| 590 |
|
|
|a Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2023. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
|
| 655 |
|
4 |
|a Electronic books.
|
| 776 |
0 |
8 |
|i Print version:
|a Speck, Ulrich
|t X-Ray Contrast Media
|d Berlin, Heidelberg : Springer Berlin / Heidelberg,c2018
|z 9783662564646
|
| 797 |
2 |
|
|a ProQuest (Firm)
|
| 856 |
4 |
0 |
|u https://ebookcentral.proquest.com/lib/matrademy/detail.action?docID=6422751
|z Click to View
|
